[Invasive adjuvant therapy after pharmacological thrombolysis: why and when? Can we answer these questions right now?].
Sousa
A G
AG
Instituto Dante Pazzanese de Cardiologia, São Paulo, SP.
Sousa
J E
JE
D015906:Angioplasty, Balloon, Coronary; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D006801:Humans; D009203:Myocardial Infarction / Q000628:therapy*; D015912:Thrombolytic Therapy; D013997:Time Factors
Terapêutica invasiva adjunta pós-trombólise farmacológica: por quê e quando? Já podemos responder a essas questões?